Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Debopam Samanta

Concepts (335)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Epilepsy
29
2025
181
13.320
 Why?
Anticonvulsants
19
2025
125
8.270
 Why?
Seizures
24
2025
198
6.340
 Why?
Tuberous Sclerosis
8
2025
37
4.400
 Why?
Spasms, Infantile
11
2025
29
4.290
 Why?
Cannabidiol
8
2025
41
4.070
 Why?
Status Epilepticus
6
2021
36
3.370
 Why?
Epilepsies, Myoclonic
5
2024
12
3.140
 Why?
Mutation
16
2023
1280
3.110
 Why?
Deep Brain Stimulation
4
2025
43
2.860
 Why?
Humans
116
2025
50673
2.700
 Why?
Electroencephalography
18
2024
304
2.540
 Why?
Intellectual Disability
5
2023
127
2.200
 Why?
Brain
10
2024
1324
2.150
 Why?
Child
41
2025
6976
2.140
 Why?
Hemiplegia
3
2021
11
2.030
 Why?
Developmental Disabilities
5
2019
120
1.700
 Why?
Epilepsy, Absence
3
2019
11
1.650
 Why?
Magnetic Resonance Imaging
16
2025
1556
1.620
 Why?
Genetic Therapy
2
2025
120
1.510
 Why?
Infant
23
2025
3656
1.460
 Why?
Algorithms
2
2025
629
1.430
 Why?
Tumor Suppressor Proteins
3
2023
127
1.410
 Why?
Neuroaxonal Dystrophies
2
2022
8
1.410
 Why?
Nervous System Malformations
3
2020
17
1.400
 Why?
Folate Receptor 1
2
2022
25
1.380
 Why?
Infant, Newborn, Diseases
2
2020
55
1.290
 Why?
Epilepsies, Partial
2
2022
12
1.290
 Why?
Ketamine
2
2020
59
1.270
 Why?
Child, Preschool
21
2025
3965
1.210
 Why?
Vagus Nerve Stimulation
2
2025
14
1.170
 Why?
Neurocutaneous Syndromes
2
2019
6
1.160
 Why?
Cadherins
2
2019
63
1.130
 Why?
Cerebral Arteries
2
2019
37
1.060
 Why?
Epilepsy, Generalized
2
2023
8
1.050
 Why?
Vigabatrin
3
2024
3
1.040
 Why?
Sirolimus
2
2017
62
1.030
 Why?
Angiofibroma
2
2015
5
0.990
 Why?
Facial Neoplasms
2
2015
22
0.980
 Why?
Nerve Tissue Proteins
2
2018
193
0.960
 Why?
Valproic Acid
2
2022
31
0.960
 Why?
Male
36
2025
25991
0.920
 Why?
Stroke
3
2019
495
0.920
 Why?
Fenfluramine
2
2024
8
0.910
 Why?
Randomized Controlled Trials as Topic
2
2024
569
0.910
 Why?
Female
32
2025
27181
0.900
 Why?
Dioxolanes
2
2024
14
0.900
 Why?
Thalamus
1
2024
38
0.890
 Why?
Pregnanolone
2
2023
6
0.870
 Why?
Treatment Outcome
12
2025
5294
0.850
 Why?
Landau-Kleffner Syndrome
1
2022
3
0.820
 Why?
Quality Improvement
2
2022
215
0.790
 Why?
Aphasia
1
2022
33
0.780
 Why?
Nervous System Diseases
2
2021
89
0.760
 Why?
Chromosome Deletion
3
2019
134
0.750
 Why?
Abnormalities, Multiple
3
2023
167
0.750
 Why?
Emergencies
1
2021
79
0.720
 Why?
Pharmaceutical Preparations
1
2021
77
0.710
 Why?
Angelman Syndrome
1
2020
1
0.700
 Why?
Transition to Adult Care
1
2020
17
0.700
 Why?
Bone Diseases, Developmental
2
2023
14
0.680
 Why?
Tooth Abnormalities
2
2023
12
0.680
 Why?
Immunoglobulins, Intravenous
1
2021
65
0.670
 Why?
Oligonucleotides, Antisense
1
2020
26
0.670
 Why?
Phenobarbital
1
2020
17
0.670
 Why?
Behavioral Symptoms
1
2019
3
0.660
 Why?
Immunologic Factors
1
2021
113
0.660
 Why?
Flunarizine
1
2019
1
0.660
 Why?
Excitatory Amino Acid Antagonists
1
2020
51
0.660
 Why?
Ocular Physiological Phenomena
1
2019
4
0.650
 Why?
Tetrasomy
1
2019
2
0.650
 Why?
Chromosomes, Human, Pair 5
1
2019
15
0.640
 Why?
Agenesis of Corpus Callosum
2
2018
11
0.640
 Why?
Sneddon Syndrome
1
2019
3
0.640
 Why?
Livedo Reticularis
1
2019
5
0.640
 Why?
Oral Ulcer
1
2019
3
0.640
 Why?
Calcium Channel Blockers
1
2019
63
0.640
 Why?
Behcet Syndrome
1
2019
7
0.630
 Why?
Transposases
1
2019
10
0.630
 Why?
Andersen Syndrome
1
2019
1
0.630
 Why?
Spinal Cord Diseases
1
2019
36
0.630
 Why?
Hydrocephalus
1
2019
43
0.630
 Why?
Receptors, GABA-B
1
2019
11
0.620
 Why?
Vitiligo
1
2019
8
0.620
 Why?
Leukoencephalopathies
1
2019
14
0.620
 Why?
Autoimmune Diseases of the Nervous System
1
2019
9
0.620
 Why?
Nephrotic Syndrome
2
2017
18
0.620
 Why?
Cytochrome-c Oxidase Deficiency
1
2018
3
0.620
 Why?
Migraine Disorders
2
2020
45
0.620
 Why?
Edema
1
2019
69
0.610
 Why?
Cerebral Infarction
1
2018
37
0.610
 Why?
Alopecia
1
2019
29
0.610
 Why?
Electron Transport Complex IV
1
2018
28
0.610
 Why?
Muscle Weakness
1
2019
44
0.610
 Why?
Physicians
1
2022
235
0.600
 Why?
Cannabinoid Receptor Agonists
1
2019
51
0.600
 Why?
Optic Atrophy
1
2018
16
0.600
 Why?
Diffuse Cerebral Sclerosis of Schilder
1
2018
8
0.600
 Why?
Amino Acyl-tRNA Synthetases
1
2018
6
0.600
 Why?
Photic Stimulation
1
2018
55
0.600
 Why?
Shab Potassium Channels
1
2018
2
0.600
 Why?
Brain Edema
1
2018
41
0.590
 Why?
Parents
1
2021
323
0.590
 Why?
Lymphohistiocytosis, Hemophagocytic
1
2018
27
0.590
 Why?
Autoimmune Diseases
1
2019
78
0.580
 Why?
Thrombocytopenia
1
2019
82
0.580
 Why?
Myoclonus
1
2018
9
0.580
 Why?
Artifacts
1
2018
54
0.580
 Why?
Biomedical Research
1
2021
244
0.580
 Why?
Mitochondrial Diseases
1
2018
41
0.580
 Why?
Adolescent
14
2025
6489
0.570
 Why?
Neurodegenerative Diseases
1
2018
74
0.570
 Why?
Practice Guidelines as Topic
1
2020
473
0.560
 Why?
Hearing Loss, Sensorineural
1
2018
76
0.550
 Why?
Health Knowledge, Attitudes, Practice
1
2021
492
0.550
 Why?
Osteochondrodysplasias
1
2017
12
0.550
 Why?
Immunologic Deficiency Syndromes
1
2017
19
0.550
 Why?
Models, Biological
1
2020
721
0.540
 Why?
Phenotype
2
2021
739
0.540
 Why?
Infant, Newborn
6
2024
2755
0.540
 Why?
Arteriosclerosis
1
2017
53
0.540
 Why?
Carotid Artery Diseases
1
2017
33
0.540
 Why?
Drug Discovery
1
2017
85
0.530
 Why?
Child Development
1
2018
192
0.530
 Why?
Prenatal Exposure Delayed Effects
1
2018
185
0.520
 Why?
Skin
1
2019
385
0.520
 Why?
Cafe-au-Lait Spots
1
2016
2
0.520
 Why?
Erythema Infectiosum
1
2015
3
0.510
 Why?
Williams Syndrome
1
2016
26
0.510
 Why?
Migraine with Aura
1
2015
4
0.510
 Why?
Corpus Callosum
2
2023
28
0.510
 Why?
Leukoencephalitis, Acute Hemorrhagic
1
2015
3
0.500
 Why?
Syndrome
6
2024
237
0.500
 Why?
Sinus Pericranii
1
2015
1
0.500
 Why?
Parvovirus B19, Human
1
2015
17
0.500
 Why?
Pulmonary Embolism
1
2017
99
0.500
 Why?
Toes
1
2015
14
0.500
 Why?
Electrodiagnosis
1
2015
12
0.500
 Why?
SOS1 Protein
1
2015
2
0.500
 Why?
Crying
1
2015
4
0.500
 Why?
Moyamoya Disease
1
2015
7
0.490
 Why?
Iatrogenic Disease
1
2015
23
0.490
 Why?
Hyperventilation
1
2015
8
0.490
 Why?
Tuberculoma
1
2015
2
0.490
 Why?
Epilepsy, Benign Neonatal
1
2015
2
0.490
 Why?
Noonan Syndrome
1
2015
12
0.490
 Why?
Neurologic Examination
1
2015
76
0.490
 Why?
Encephalitis
1
2016
40
0.490
 Why?
Ocular Motility Disorders
1
2015
17
0.480
 Why?
Mutism
1
2015
3
0.480
 Why?
NAV1.2 Voltage-Gated Sodium Channel
1
2015
3
0.480
 Why?
Communication
3
2022
257
0.480
 Why?
TOR Serine-Threonine Kinases
1
2015
78
0.480
 Why?
Repressor Proteins
2
2023
149
0.480
 Why?
Diagnosis, Differential
7
2020
1034
0.470
 Why?
Trisomy
1
2014
27
0.470
 Why?
Influenza, Human
1
2015
86
0.460
 Why?
KCNQ2 Potassium Channel
1
2014
9
0.460
 Why?
Energy Drinks
1
2014
6
0.460
 Why?
Neurology
1
2015
42
0.450
 Why?
Vasoconstriction
1
2014
56
0.450
 Why?
Benzodiazepines
1
2014
70
0.450
 Why?
Osteomyelitis
1
2015
128
0.440
 Why?
Membrane Proteins
1
2016
341
0.440
 Why?
Sleep
1
2014
183
0.420
 Why?
Enzyme Inhibitors
1
2015
374
0.420
 Why?
Quality of Life
4
2025
858
0.400
 Why?
Magnetic Resonance Angiography
3
2019
71
0.400
 Why?
Immunosuppressive Agents
3
2019
227
0.390
 Why?
Consensus
2
2025
160
0.390
 Why?
Pediatrics
1
2015
286
0.380
 Why?
Receptors, N-Methyl-D-Aspartate
2
2022
127
0.340
 Why?
Diffusion Magnetic Resonance Imaging
3
2017
125
0.340
 Why?
Clinical Trials as Topic
2
2024
488
0.340
 Why?
Caregivers
2
2021
225
0.320
 Why?
Recurrence
3
2019
663
0.310
 Why?
Echinocandins
1
2008
64
0.300
 Why?
Mycoses
1
2008
159
0.280
 Why?
Gastroesophageal Reflux
2
2019
50
0.270
 Why?
Retrospective Studies
7
2025
6294
0.270
 Why?
Antifungal Agents
1
2008
342
0.250
 Why?
Administration, Topical
2
2015
67
0.250
 Why?
Adult
6
2025
13636
0.240
 Why?
Seizures, Febrile
1
2024
3
0.230
 Why?
Meta-Analysis as Topic
1
2024
38
0.230
 Why?
Intralaminar Thalamic Nuclei
1
2024
6
0.220
 Why?
Databases, Factual
2
2024
676
0.220
 Why?
Psychosurgery
1
2023
4
0.220
 Why?
Laser Therapy
1
2023
83
0.210
 Why?
Speech Disorders
1
2022
16
0.200
 Why?
Ethosuximide
1
2022
5
0.200
 Why?
Clonazepam
1
2022
6
0.200
 Why?
Electrodes, Implanted
1
2022
30
0.200
 Why?
Cluster Analysis
1
2023
216
0.200
 Why?
Stereotaxic Techniques
1
2022
38
0.200
 Why?
Death, Sudden
1
2022
10
0.200
 Why?
GTPase-Activating Proteins
1
2022
23
0.190
 Why?
Palliative Care
1
2024
189
0.190
 Why?
Concept Formation
1
2021
12
0.190
 Why?
Perivascular Epithelioid Cell Neoplasms
1
2021
4
0.190
 Why?
Freedom
1
2021
3
0.190
 Why?
Diazepam
1
2021
17
0.190
 Why?
Folic Acid
1
2022
141
0.190
 Why?
Drug Interactions
1
2022
207
0.180
 Why?
Fibroma
1
2021
39
0.180
 Why?
Risk Factors
2
2020
3731
0.180
 Why?
Adrenocorticotropic Hormone
2
2022
31
0.180
 Why?
Personal Satisfaction
1
2021
78
0.180
 Why?
Soft Tissue Neoplasms
1
2021
54
0.180
 Why?
Brain Diseases
1
2021
83
0.180
 Why?
Dihydroergotamine
1
2020
4
0.180
 Why?
Perception
1
2021
116
0.170
 Why?
Mental Disorders
1
2025
419
0.170
 Why?
Transcription Factors
2
2023
566
0.170
 Why?
Facies
2
2023
33
0.170
 Why?
Diet Therapy
1
2020
8
0.170
 Why?
Genetic Diseases, Inborn
1
2020
20
0.170
 Why?
Clinical Protocols
1
2020
111
0.170
 Why?
Treatment Failure
1
2020
120
0.160
 Why?
Anesthetics
1
2020
36
0.160
 Why?
Ubiquitin-Protein Ligases
1
2020
94
0.160
 Why?
Leukomalacia, Periventricular
1
2019
12
0.160
 Why?
Muscle Hypotonia
1
2019
21
0.160
 Why?
Learning
1
2021
158
0.160
 Why?
Chromosomes, Human, Pair 7
1
2019
29
0.160
 Why?
Patient-Centered Care
1
2021
130
0.160
 Why?
Matrix Attachment Region Binding Proteins
1
2020
37
0.160
 Why?
HLA-B51 Antigen
1
2019
2
0.160
 Why?
Qualitative Research
1
2021
352
0.160
 Why?
Craniofacial Abnormalities
1
2019
27
0.160
 Why?
Analgesics, Non-Narcotic
1
2020
117
0.160
 Why?
Ventriculoperitoneal Shunt
1
2019
26
0.160
 Why?
Heart Septal Defects, Atrial
1
2019
46
0.160
 Why?
Disease Management
1
2020
179
0.160
 Why?
Potassium Channels, Inwardly Rectifying
1
2019
7
0.160
 Why?
Ventricular Premature Complexes
1
2019
7
0.160
 Why?
Microcephaly
1
2019
41
0.160
 Why?
Melkersson-Rosenthal Syndrome
1
2018
4
0.150
 Why?
Facial Nerve Diseases
1
2018
6
0.150
 Why?
Referral and Consultation
1
2021
290
0.150
 Why?
Syncope
1
2019
29
0.150
 Why?
Nocturnal Myoclonus Syndrome
1
2018
13
0.150
 Why?
Cerebral Veins
1
2018
15
0.150
 Why?
Facial Paralysis
1
2018
23
0.150
 Why?
Anti-Arrhythmia Agents
1
2019
80
0.150
 Why?
Deglutition Disorders
1
2019
77
0.150
 Why?
Health Personnel
1
2021
251
0.150
 Why?
Acute Disease
1
2019
374
0.150
 Why?
Fatal Outcome
1
2019
197
0.150
 Why?
Video Recording
1
2018
84
0.150
 Why?
Fibrinolytic Agents
1
2019
125
0.150
 Why?
Frameshift Mutation
1
2018
16
0.150
 Why?
Combined Modality Therapy
1
2020
642
0.140
 Why?
Anti-Inflammatory Agents
1
2019
167
0.140
 Why?
Fear
1
2018
83
0.140
 Why?
India
1
2017
52
0.140
 Why?
Platelet Aggregation Inhibitors
1
2019
174
0.140
 Why?
Cerebellum
1
2018
133
0.140
 Why?
History, 21st Century
1
2017
57
0.140
 Why?
History, 20th Century
1
2017
101
0.140
 Why?
Neurotoxicity Syndromes
1
2017
45
0.140
 Why?
Methotrexate
1
2017
77
0.140
 Why?
Pandemics
1
2021
556
0.130
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2017
82
0.130
 Why?
Animals
3
2022
13156
0.130
 Why?
Anti-Infective Agents
1
2017
99
0.130
 Why?
Aldehyde Dehydrogenase
1
2016
25
0.130
 Why?
Hormones
1
2016
57
0.130
 Why?
Influenza B virus
1
2015
4
0.130
 Why?
Delayed Diagnosis
1
2016
24
0.130
 Why?
Arkansas
1
2021
1973
0.120
 Why?
Chromosomes, Human, Pair 3
1
2015
18
0.120
 Why?
North America
1
2015
65
0.120
 Why?
Cerebral Angiography
1
2015
97
0.120
 Why?
Antibiotics, Antineoplastic
1
2015
77
0.120
 Why?
Chromosomes, Human, Pair 9
1
2014
13
0.120
 Why?
Brain Waves
1
2014
16
0.120
 Why?
Complementary Therapies
1
2015
26
0.120
 Why?
Drug Resistance
1
2015
65
0.120
 Why?
Antiemetics
1
2014
31
0.110
 Why?
Polymerase Chain Reaction
1
2015
451
0.110
 Why?
Headache
1
2014
74
0.110
 Why?
Glutamine
1
2015
175
0.110
 Why?
Mutation, Missense
1
2014
103
0.110
 Why?
Vomiting
1
2014
71
0.110
 Why?
Arginine
1
2015
187
0.110
 Why?
Decision Making, Computer-Assisted
1
2013
4
0.110
 Why?
Analgesics
1
2014
117
0.100
 Why?
Diagnostic Errors
1
2013
66
0.100
 Why?
Evidence-Based Medicine
1
2013
255
0.090
 Why?
Inflammation
1
2016
610
0.090
 Why?
Pregnancy
1
2018
2456
0.090
 Why?
Signal Transduction
1
2017
1618
0.090
 Why?
Antineoplastic Agents
1
2017
1173
0.080
 Why?
Dysentery
1
2009
1
0.080
 Why?
Trichuriasis
1
2009
1
0.080
 Why?
Trichuris
1
2009
1
0.080
 Why?
Anesthesia, Intravenous
1
2008
12
0.080
 Why?
Eosinophils
1
2009
40
0.080
 Why?
Lipopeptides
1
2008
63
0.070
 Why?
Amyloidosis
1
2009
79
0.070
 Why?
Inflammatory Bowel Diseases
1
2009
53
0.070
 Why?
Tuberculosis
1
2009
131
0.070
 Why?
Candidiasis
1
2008
112
0.070
 Why?
Aspergillosis
1
2008
125
0.070
 Why?
Kidney Diseases
1
2009
213
0.070
 Why?
Prospective Studies
2
2023
2395
0.060
 Why?
Clinical Trials, Phase III as Topic
1
2025
47
0.060
 Why?
Spasm
1
2024
9
0.060
 Why?
Observer Variation
1
2024
140
0.060
 Why?
Feedback
1
2024
53
0.050
 Why?
Kaplan-Meier Estimate
1
2025
463
0.050
 Why?
Probability
1
2023
164
0.050
 Why?
Young Adult
2
2025
4114
0.050
 Why?
Neuroimaging
1
2023
87
0.050
 Why?
Neurosurgical Procedures
1
2024
126
0.050
 Why?
Potassium Channels
1
2021
33
0.050
 Why?
Registries
1
2024
565
0.040
 Why?
Reproducibility of Results
1
2024
1199
0.040
 Why?
Administration, Intravenous
1
2020
70
0.040
 Why?
Sleep Stages
1
2020
41
0.040
 Why?
Age of Onset
1
2020
109
0.040
 Why?
Cognition
1
2022
346
0.040
 Why?
Follow-Up Studies
1
2025
2246
0.040
 Why?
Immunohistochemistry
1
2021
958
0.040
 Why?
Aged
1
2025
9770
0.020
 Why?
Software
1
2013
276
0.020
 Why?
Internet
1
2013
262
0.020
 Why?
Middle Aged
1
2025
12648
0.020
 Why?
Antinematodal Agents
1
2009
2
0.020
 Why?
Mebendazole
1
2009
2
0.020
 Why?
Leukemoid Reaction
1
2009
6
0.020
 Why?
Antitubercular Agents
1
2009
103
0.020
 Why?
Colonoscopy
1
2009
100
0.020
 Why?
Prognosis
1
2009
1979
0.010
 Why?
Samanta's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (335) concept(s)
_
Co-Authors Expand Description
See all (14) people
_
Similar People Expand Description
See all (30) people
_
Same Department Expand Description
Search Department